It provides range of vision beyond one focal point. Bausch + Lomb launched the enVista Aspire monofocal and toric IOLs in the European Union, according to a press release. Using intermediate ...

City Therapeutics will develop an RNAi clinical candidate for intravitreal administration targeting retinal diseases, including geographic atrophy. Bausch + Lomb will manage IND-enabling studies, ...

Not long ago, thermal scopes were superfluous gadgets. Now, they’re essential kit for serious predator and hog hunters. This collection of thermal sights includes military-grade scopes that cost more ...

London, UK, 13 January 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing ...

Let’s dig into the relative performance of VF Corp (NYSE:VFC) and its peers as we unravel the now-completed Q3 apparel and accessories earnings season. Thanks to social media and the internet ...

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

In the US, enVista Aspire is the first Low-Cyl toric IOL below 1.5D at the IOL plane, enhancing treatment options. Bausch + Lomb announced the commercial launch of its enVista Aspire monofocal and ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic atrophy (GA). The early-stage deal breaks down like this: City gets an ...

Royal fans have noticed one thing about Meghan and Harry's children that they get from Princess Diana after the couple released their annual Christmas card last month. The couple's Christmas card ...

Fans have been sent into a frenzy amid speculation that Zendaya and Tom Holland are engaged. Zendaya and Tom have been dating for some years now, with many people (myself included) hoping that the ...